DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 10 of 10 descriptions
Filter by
Reset
No.
薬物名（臨床試験情報から抽出）
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
指定難病告示番号
1
SATRALIZUMAB
1件:
Satralizumab
Satralizumab
1件:
D11079
D11079
(Name:
Satralizumab
)
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
3件:
11
11
,
13
,
86
2
Satralizumab
(120 mg/PFS with NSD)
1件:
Satralizumab
Satralizumab
1件:
D11079
D11079
(Name:
Satralizumab
)
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
13
13
3
Satralizumab
(120 mg/vial)
1件:
Satralizumab
Satralizumab
1件:
D11079
D11079
(Name:
Satralizumab
)
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
13
13
4
Satralizumab
(120mg/vial)
1件:
Satralizumab
Satralizumab
1件:
D11079
D11079
(Name:
Satralizumab
)
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
13
13
5
Satralizumab
(Genetical Recombination)
1件:
Satralizumab
Satralizumab
1件:
D11079
D11079
(Name:
Satralizumab
)
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
86
86
6
Satralizumab
(r-INN)
1件:
Satralizumab
Satralizumab
1件:
D11079
D11079
(Name:
Satralizumab
)
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
13
13
7
Satralizumab
(RO5333787/Enspryng /SA237)
1件:
Satralizumab
Satralizumab
1件:
D11079
D11079
(Name:
Satralizumab
)
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
13
13
8
Satralizumab
(RO5333787/Enspryng/SA237)
1件:
Satralizumab
Satralizumab
1件:
D11079
D11079
(Name:
Satralizumab
)
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
13
13
9
Satralizumab
(RO5333787/SA237)
1件:
Satralizumab
Satralizumab
1件:
D11079
D11079
(Name:
Satralizumab
)
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
13
13
10
Satralizumab
120 mg
1件:
Satralizumab
Satralizumab
1件:
D11079
D11079
(Name:
Satralizumab
)
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
13
13